Thank you, Michael. Good morning, all, and thank you for dialing in this morning. I'll cover the highlights for the quarter ended December 31, and a few of the subsequent events before concluding with some comments on our near-term outlook for the company. Beginning with our last quarter results. fundings were strong last quarter, totaling $152 million, including six new portfolio companies representing a combination of attractive refinancing opportunities and a pickup in the pace of lower middle-market buyout activity. As anticipated, exits and prepayments spiked to $165 million. However, since the inflows include a large equity gain on ARA of $64 million, our total debt investments actually increased by $45 million on the quarter. Investment income for the period declined by $1.8 million to $22 million as the decline in SOFR rates accounting for the bulk of the 90 basis point reduction in the weighted average portfolio yield to 13.1%. Average earning assets also declined 2.6% with the magnitude of portfolio turnover and because of an additional investment being added to our nonearning asset list. Interest and financing costs declined by $700,000 or 13% on lower average line borrowings and net management fees declined by $1.7 million with the surge in new deal origination fee credits, leading to an increase in net investment income of $300,000 to $11.2 million. Net realized gains came in at $58 million for the quarter and contributed to the $15.9 million of net realized and unrealized gains, which lifted our ROE to just over 22% for the quarter and the TTM period. With respect to the portfolio, the reinvestment of the ARA proceeds lifted our senior debt holdings to 73.4% of the fair value of the portfolio and total debt holdings by 5% to 89.3% of the portfolio at fair value. During the quarter, we foreclosed on EG's, a regional QSR based in the Southwest and today are well into the operational restructuring of the business, including new management, the closing of unprofitable locations and significant overhead cost reductions. We expect to achieve the timely completion of this process, which should result in the sale of the investment or return of the investment to our performing status. With the addition of this company to our nonearning investments, the total at the end of the quarter rose to $52.7 million at cost or $28.5 million or 4% of assets at fair value. The bulk of the $15.9 million of net appreciation for the quarter was led by our equity co-investment in Sokol Foods, which was sold to a strategic buyer shortly after the end of the quarter, and a small incremental appreciation of our position in ARA. The improved performance of several smaller manufacturing consumer and service-oriented businesses also outpaced the underperformers and we elected to exit our small underperforming position in DKI at a modest loss. Following the end of the quarter, we exited two additional portfolio investments representing debt proceeds of $26.1 million and a $5.8 million equity proceeds from our Sokol investment. And consistent with last quarter's activity, we maintained our momentum by closing two new portfolio investments thus far this quarter, representing a total originations of $38 million. And reflecting on our outlook for the next quarter or two, I'd like to leave with the following. We continue to expect the elevated level of portfolio exit and repayments to continue for the next one to two quarters and are very focused on the timely redeployment of these exit proceeds to maintain our investment asset base. Prepayments or closing fees are expected to remain elevated during this period of portfolio turnover and the magnitude of margin compression in the lower middle market has been more muted as evidenced by our originations last quarter which were closed at a weighted average spread above 700 basis points over SOFR and a weighted average closing leverage of 3.4x EBITDA. We continue to see a healthy level of attractive lower middle market financing opportunities, typically under $10 million of EBITDA, and where low leverage or pricing dictate, we will consider teaming with commercial banks to blend down the overall cost of the financings we can deliver. In addition to recycling some mature investments, we expect to continue to benefit from an incumbent position as the originator, lead lender and in some case equity co-investor in the newer vintage growth-oriented businesses as they look to grow through acquisition or expansion and support the appreciation of their equity position. We ended the quarter with a conservative leverage position with debt at 70% of NAV and the bulk of our bank credit facility available to support the growth of our earning assets and shareholder distributions in the coming year. And now I'd like to turn the call over to Nicole Schaltenbrand, the CFO of Gladstone Capital to provide some more details on the funds results for the quarter.